Immune mechanisms in the pathogenesis of demyelinating diseases.
The loss of myelin which characterises many human and experimental demyelinating diseases, among them multiple sclerosis, is thought to be immune mediated, but the precise mechanisms responsible remain unknown despite intense research. Normally, myelin in the central nervous system (CNS) is protected from systemic immune responses by the blood brain barrier, which separates nervous tissue from the peripheral circulation. Here we review evidence suggesting that an understanding of the demyelinating disorders may be helped by considering their immune pathogenesis in two stages. The first is damage to the blood brain barrier; this appears to be cell mediated, and allows infiltration into the CNS of other immune effectors. These include complement and also macrophages, which together may mediate the second stage, injury to the myelin/oligodendrocyte complex.
Scolding
N
N
Department of Medicine, University of Wales College of Medicine, Cardiff.
Linington
C
C
Compston
A
A
D000818:Animals; D001812:Blood-Brain Barrier / Q000276:immunology; D003165:Complement System Proteins; D003711:Demyelinating Diseases / Q000209:etiology* / Q000276:immunology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000209:etiology; D006801:Humans; D008264:Macrophages / Q000276:immunology; D008954:Models, Biological; D009103:Multiple Sclerosis / Q000209:etiology; D009186:Myelin Sheath / Q000276:immunology; D009836:Oligodendroglia / Q000276:immunology
D003165:Complement System Proteins